Legal & General Group
GWPH

Legal & General Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Legal & General Group’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,622
Closed -$2.09M – 3771
2021
Q1 		$2.09M Buy
9,622
+19
+0.2% +$3.57K ﹤0.01% 1962
2020
Q4 		$1.11M Buy
9,603
+1,093
+13% +$122K ﹤0.01% 2083
2020
Q3 		$830K Buy
8,510
+496
+6% +$57.1K ﹤0.01% 2079
2020
Q2 		$984K Buy
8,014
+2,932
+58% +$333K ﹤0.01% 1985
2020
Q1 		$446K Buy
5,082
+1,434
+39% +$152K ﹤0.01% 2100
2019
Q4 		$381K Buy
3,648
+3,141
+620% +$352K ﹤0.01% 2276
2019
Q3 		$58K Buy
507
+87
+21% +$13.2K ﹤0.01% 2692
2019
Q2 		$72K Buy
420
+271
+182% +$46.9K ﹤0.01% 2645
2019
Q1 		$25K Hold
149
– – ﹤0.01% 3024
2018
Q4 		$14K Sell
149
-9
-6% -$1.18K ﹤0.01% 3207
2018
Q3 		$27K Hold
158
– – ﹤0.01% 3093
2018
Q2 		$22K Buy
+158
New +$22.4K ﹤0.01% 3162

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Legal & General Group's GWPH Position: Q2 2021 in Review

Legal & General Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 9,622 shares — an estimated $2.09M sold.

Legal & General Group first reported a position in GWPH in Q2 2018 and held it in 12 quarters. The position peaked at $2.09M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Legal & General Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 9,622 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.09M.
  • Legal & General Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 12 quarters.
  • Legal & General Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.09M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.